At its January meeting, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending revisions to the approved indications for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results